Title:
SPIRO COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/017270
Kind Code:
A1
Abstract:
The present application relates to the technical field of chemical drugs, and to a spiro compound as represented by general formula (I), or an isomer, racemate, or pharmaceutically acceptable salt thereof, as a 3C-like protease inhibitor, and a method for treating multiple specific diseases or disorders using same.
More Like This:
| WO/2004/022554 | QUINAZOLINONE DERIVATIVES |
| WO/1991/013887 | COMPOUND TAN-1251, ITS DERIVATIVES, THEIR PRODUCTION AND USE |
| WO/2008/036755 | SPIRO BENZAZEPINES USED AS VASOPRESSIN ANTAGONISTS |
Inventors:
LAI YINGJIE (CN)
XIONG JINFENG (CN)
XIAO YING (CN)
DUAN ZHENFANG (CN)
WANG BIN (CN)
LI ZHONGLE (CN)
LIU HANBIN (CN)
YUE XIAOLIANG (CN)
XIONG JINFENG (CN)
XIAO YING (CN)
DUAN ZHENFANG (CN)
WANG BIN (CN)
LI ZHONGLE (CN)
LIU HANBIN (CN)
YUE XIAOLIANG (CN)
Application Number:
PCT/CN2023/108016
Publication Date:
January 25, 2024
Filing Date:
July 19, 2023
Export Citation:
Assignee:
SHENZHEN SALUBRIS PHARM CO LTD (CN)
International Classes:
C07D487/10; A61K31/437; A61P31/14
Domestic Patent References:
| WO2022109363A1 | 2022-05-27 | |||
| WO2012099454A1 | 2012-07-26 |
Other References:
江文峰等 (JIANG, WENFENG ET AL.): "氘代作用在药物研究中的应用 (Application of Deuteration in Drug Research)", 齐鲁药事 (QILU PHARMACEUTICAL AFFAIRS), vol. 29, no. 11, 31 December 2010 (2010-12-31), XP008173943
Download PDF: